Literature DB >> 18250922

Determinants of multidrug-resistant tuberculosis in South Africa: results from a national survey.

K Weyer1, J Brand, J Lancaster, J Levin, M van der Walt.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18250922

Source DB:  PubMed          Journal:  S Afr Med J


× No keyword cloud information.
  23 in total

1.  Risk of Death among HIV Co-Infected Multidrug Resistant Tuberculosis Patients, Compared To Mortality in the General Population of South Africa.

Authors:  Samuel Om Manda; Lieketseng J Masenyetse; Joey L Lancaster; Martie L van der Walt
Journal:  J AIDS Clin Res       Date:  2013-07-02

2.  Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.

Authors:  Rinat Sergeev; Caroline Colijn; Megan Murray; Ted Cohen
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

3.  Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.

Authors:  Wondemagegn Mulu; Daniel Mekonnen; Mulat Yimer; Aschalew Admassu; Bayeh Abera
Journal:  Afr Health Sci       Date:  2015-06       Impact factor: 0.927

4.  Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.

Authors:  Helen S Cox; Cheryl McDermid; Virginia Azevedo; Odelia Muller; David Coetzee; John Simpson; Marinus Barnard; Gerrit Coetzee; Gilles van Cutsem; Eric Goemaere
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

5.  Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.

Authors:  Martha L van der Walt; Karen Shean; Piet Becker; Karen H Keddy; Joey Lancaster
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey.

Authors:  Nazir Ahmed Ismail; Lindiwe Mvusi; Ananta Nanoo; Andries Dreyer; Shaheed V Omar; Sanni Babatunde; Thabo Molebatsi; Martie van der Walt; Adeboye Adelekan; Varough Deyde; Chikwe Ihekweazu; Shabir A Madhi
Journal:  Lancet Infect Dis       Date:  2018-04-21       Impact factor: 25.071

7.  First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis.

Authors:  N Alikhanova; I Akhundova; M Seyfaddinova; E Mammadbayov; V Mirtskulava; S Rüsch-Gerdes; R Bayramov; J Suleymanova; K Kremer; A Dadu; C D Acosta; A D Harries; M Dara
Journal:  Public Health Action       Date:  2014-10-21

8.  Characteristics of multidrug-resistant tuberculosis in Namibia.

Authors:  Philip M Ricks; Farai Mavhunga; Surbhi Modi; Rosalia Indongo; Abbas Zezai; Lauren A Lambert; Nick DeLuca; Jamie S Krashin; Allyn K Nakashima; Timothy H Holtz
Journal:  BMC Infect Dis       Date:  2012-12-29       Impact factor: 3.090

9.  Factors Associated with Multi-Drug Resistant Tuberculosis among TB Patients in Selected Treatment Centers of Amhara Region: A Case-Control Study.

Authors:  Getahun Yeshiwas Ambaye; Gebiyaw Wudie Tsegaye
Journal:  Ethiop J Health Sci       Date:  2021-01

10.  Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.

Authors:  Martha Van der Walt; Johanna Lancaster; Ronel Odendaal; Jeanne Garcia Davis; Karen Shean; Jason Farley
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.